-
Je něco špatně v tomto záznamu ?
Development and evaluation of innovative enteric-coated capsules for colon-specific delivery of hydrophilic biomaterials
N. Fülöpová, K. Brückner, J. Muselík, S. Pavloková, A. Franc
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- bakteriální polysacharidy chemie MeSH
- biokompatibilní materiály chemie MeSH
- celulosa * chemie analogy a deriváty MeSH
- deriváty hypromelózy chemie MeSH
- hydrofobní a hydrofilní interakce * MeSH
- hydrogely chemie MeSH
- kofein chemie aplikace a dávkování MeSH
- kolon * metabolismus MeSH
- kyseliny polymethakrylové chemie MeSH
- lékové transportní systémy * metody MeSH
- léky s prodlouženým účinkem chemie MeSH
- polymery chemie MeSH
- polyvinyly chemie MeSH
- tobolky * MeSH
- uvolňování léčiv * MeSH
- želatina * chemie MeSH
- železité sloučeniny chemie aplikace a dávkování MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVE: This research aims to design and evaluate an enteric-coated hard capsule dosage form for targeted delivery of biological materials, such as FMT (fecal microbiota transplant) or live microbes, to the distal parts of the GIT. The capsules are designed to be internally protected against destruction by hydrophilic filling during passage through the digestive tract. METHODS: Hard gelatin capsules and DRcapsTMcapsules based on HPMC and gellan were used to encapsulate a hydrophilic body temperature-liquefying gelatin hydrogel with caffeine or insoluble iron oxide mixture. Different combinations of polymers were tested for the internal (ethylcellulose, Eudragit® E, and polyvinyl acetate) and external (Eudragit® S, Acryl-EZE®, and cellacefate) coating. The external protects against the acidic gastric environment, while the internal protects against the liquid hydrophilic filling during passage. Coated capsules were evaluated using standard disintegration and modified dissolution methods for delayed-release dosage forms. RESULTS: Combining suitable internal (ethylcellulose 1.0 %) and external (Eudragit® S 20.0 %) coating of DRcapsTM capsules with the wiping and immersion method achieved colonic release times. While most coated capsules met the pharmaceutical requirements for delayed release, one combination stood out. Colonic times were indicated by the dissolution of soluble caffeine (during 120-720 min) measured by the dissolution method, and capsule rupture was indicated by the release of insoluble iron oxide (after 480 min) measured by the disintegration method. This promising result demonstrates the composition's suitability and potential to protect the content until it's released, inspiring hope for the future of colon-targeted delivery systems and its potential for the pharmaceutical and biomedical fields. CONCLUSION: Innovative and easy capsule coatings offer significant potential for targeted drugs, especially FMT water suspension, to the GIT, preferably the colon. The administration method is robust and not considerably affected by the quantity of internal or external coatings. It can be performed in regular laboratories without specialized individual and personalized treatment equipment, making it a practical and feasible method for drug delivery.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25002843
- 003
- CZ-PrNML
- 005
- 20250206103912.0
- 007
- ta
- 008
- 250121e20241122ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijpharm.2024.124991 $2 doi
- 035 __
- $a (PubMed)39580105
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Fülöpová, Nicole $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Brno 612 00, Czech Republic
- 245 10
- $a Development and evaluation of innovative enteric-coated capsules for colon-specific delivery of hydrophilic biomaterials / $c N. Fülöpová, K. Brückner, J. Muselík, S. Pavloková, A. Franc
- 520 9_
- $a OBJECTIVE: This research aims to design and evaluate an enteric-coated hard capsule dosage form for targeted delivery of biological materials, such as FMT (fecal microbiota transplant) or live microbes, to the distal parts of the GIT. The capsules are designed to be internally protected against destruction by hydrophilic filling during passage through the digestive tract. METHODS: Hard gelatin capsules and DRcapsTMcapsules based on HPMC and gellan were used to encapsulate a hydrophilic body temperature-liquefying gelatin hydrogel with caffeine or insoluble iron oxide mixture. Different combinations of polymers were tested for the internal (ethylcellulose, Eudragit® E, and polyvinyl acetate) and external (Eudragit® S, Acryl-EZE®, and cellacefate) coating. The external protects against the acidic gastric environment, while the internal protects against the liquid hydrophilic filling during passage. Coated capsules were evaluated using standard disintegration and modified dissolution methods for delayed-release dosage forms. RESULTS: Combining suitable internal (ethylcellulose 1.0 %) and external (Eudragit® S 20.0 %) coating of DRcapsTM capsules with the wiping and immersion method achieved colonic release times. While most coated capsules met the pharmaceutical requirements for delayed release, one combination stood out. Colonic times were indicated by the dissolution of soluble caffeine (during 120-720 min) measured by the dissolution method, and capsule rupture was indicated by the release of insoluble iron oxide (after 480 min) measured by the disintegration method. This promising result demonstrates the composition's suitability and potential to protect the content until it's released, inspiring hope for the future of colon-targeted delivery systems and its potential for the pharmaceutical and biomedical fields. CONCLUSION: Innovative and easy capsule coatings offer significant potential for targeted drugs, especially FMT water suspension, to the GIT, preferably the colon. The administration method is robust and not considerably affected by the quantity of internal or external coatings. It can be performed in regular laboratories without specialized individual and personalized treatment equipment, making it a practical and feasible method for drug delivery.
- 650 12
- $a tobolky $7 D002214
- 650 12
- $a kolon $x metabolismus $7 D003106
- 650 12
- $a hydrofobní a hydrofilní interakce $7 D057927
- 650 12
- $a celulosa $x chemie $x analogy a deriváty $7 D002482
- 650 12
- $a lékové transportní systémy $x metody $7 D016503
- 650 12
- $a želatina $x chemie $7 D005780
- 650 12
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a kofein $x chemie $x aplikace a dávkování $7 D002110
- 650 _2
- $a kyseliny polymethakrylové $x chemie $7 D011109
- 650 _2
- $a železité sloučeniny $x chemie $x aplikace a dávkování $7 D005290
- 650 _2
- $a bakteriální polysacharidy $x chemie $7 D011135
- 650 _2
- $a léky s prodlouženým účinkem $x chemie $7 D003692
- 650 _2
- $a biokompatibilní materiály $x chemie $7 D001672
- 650 _2
- $a hydrogely $x chemie $7 D020100
- 650 _2
- $a polymery $x chemie $7 D011108
- 650 _2
- $a polyvinyly $x chemie $7 D011145
- 650 _2
- $a deriváty hypromelózy $x chemie $7 D065347
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Brückner, Kateřina $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Brno 612 00, Czech Republic
- 700 1_
- $a Muselík, Jan $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Brno 612 00, Czech Republic
- 700 1_
- $a Pavloková, Sylvie $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Brno 612 00, Czech Republic. Electronic address: pavlokovas@pharm.muni.cz
- 700 1_
- $a Franc, Aleš $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Brno 612 00, Czech Republic
- 773 0_
- $w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 668 (20241122), s. 124991
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39580105 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206103907 $b ABA008
- 999 __
- $a ok $b bmc $g 2262940 $s 1238850
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 668 $c - $d 124991 $e 20241122 $i 1873-3476 $m International journal of pharmaceutics $n Int J Pharm $x MED00002359
- LZP __
- $a Pubmed-20250121